28 November 2018
Visiongain has launched a new pharma report Global Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease
Neurostimulation is an advanced treatment which helps to reduce certain types of chronic pain. Neurostimulation works by intercepting pain signals before they reach the brain. are different types of neurostimulation devices available in the market, namely spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, and cortical stimulators among others.
The lead analyst of the report commented "The leading medical device manufacturers are focusing on entering the emerging Asia-Pacific & Latin American countries to open manufacturing facility to capture the low-cost manufacturing advantage and to cater the significantly rising demand for medical devices from these regions. Thus, rising demand for medical devices from emerging markets is expected to create significant opportunities for global neurostimulation devices market vendors and the overall market."
Leading companies featured in the report include Advanced Bionics, Boston Scientific Corporation, Cochlear ltd, Cyberonics, Medtronic, Neuronetics Inc, Nervo Corp., Cogentic Medical Inc, St Jude Medicall, NDI Medical
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.